A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer targetZachary T. Freeman, Charles G. Drake, Daniel H. Hovelson et al.|Journal of Clinical Investigation|2020Cited by 133
Niraparib Shows Superior Tissue Distribution and Efficacy in a Prostate Cancer Bone Metastasis Model Compared with Other PARP InhibitorsLinda A. Snyder, Rao N. V. S. Mamidi|Molecular Cancer Therapeutics|2022Cited by 4